Search results with tag "Therapeutic class overview benign prostatic"

Therapeutic Class Overview Benign Prostatic Hyperplasia ...

• A systematic review of alfuzosin studies showed a greater improvement in the primary outcome (IPSS) over placebo (weighted mean difference, -1.8 points; 95% confidence interval [CI], -2.49 to -

  Overview, Class, Therapeutic, Benign, Therapeutic class overview benign prostatic, Prostatic